FDA Orange Book · active-ingredient family
Fluocinonide
Fluocinonide: 6 brands, 41 generics; first approved Apr 06, 1984; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available — 41 ANDA applications approved.
Brands (NDA)
6
Generics (ANDA)
41
Listed patents
0
Presentations
48
Originator applications
Brand (NDA) products
BAUSCHNDA 0217582005
BAUSCHNDA 0217582005
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.1% | CREAM | TOPICAL | Rx | AB |
FLUOCINONIDERLDSUN PHARMA CANADANDA 0191171984
FLUOCINONIDERLD
SUN PHARMA CANADANDA 0191171984
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM | TOPICAL | Discontinued | — |
LIDEXRLDALVOGENNDA 0188491984
LIDEXRLD
ALVOGENNDA 0188491984
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION | TOPICAL | Discontinued | — |
LIDEXRLDALVOGENNDA 016908—2 strengths
LIDEXRLD
ALVOGENNDA 016908—2 strengths
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM | TOPICAL | Discontinued | — |
| 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM | TOPICAL | Discontinued | — |
FLUOCINONIDERLDALVOGENNDA 017373—
FLUOCINONIDERLD
ALVOGENNDA 017373—
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL | TOPICAL | Discontinued | — |
LIDEXRLDALVOGENNDA 016909—
LIDEXRLD
ALVOGENNDA 016909—
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | OINTMENT | TOPICAL | Discontinued | — |
Abbreviated applications
Generic (ANDA) products (41)
QUAGENANDA 2163892025
QUAGENANDA 2163892025
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Rx | AT |
ZYDUS LIFESCIENCESANDA 2089892020
ZYDUS LIFESCIENCESANDA 2089892020
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.1% | CREAM | TOPICAL | Rx | AB |
XIROMEDANDA 2129762019
XIROMEDANDA 2129762019
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | OINTMENT | TOPICAL | Rx | AB |
ENCUBEANDA 2117582019
ENCUBEANDA 2117582019
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.1% | CREAM | TOPICAL | Discontinued | — |
SCIEGEN PHARMSANDA 2075542019
SCIEGEN PHARMSANDA 2075542019
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Rx | AT |
ENCUBE ETHICALSANDA 2096992018
ENCUBE ETHICALSANDA 2096992018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Rx | AT |
ENCUBEANDA 2114102018
ENCUBEANDA 2114102018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB1 |
PAI HOLDINGS PHARMANDA 2076802018
PAI HOLDINGS PHARMANDA 2076802018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | OINTMENT | TOPICAL | Discontinued | — |
AMNEALANDA 2105542018
AMNEALANDA 2105542018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB1 |
ZYDUS PHARMSANDA 2089482018
ZYDUS PHARMSANDA 2089482018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Rx | AT |
PADAGIS USANDA 2090302018
PADAGIS USANDA 2090302018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | GEL | TOPICAL | Rx | AB |
AMNEALANDA 2111112018
AMNEALANDA 2111112018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.1% | CREAM | TOPICAL | Discontinued | — |
CHARTWELL RXANDA 2091182018
CHARTWELL RXANDA 2091182018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Rx | AT |
MACLEODS PHARMS LTDANDA 2092832018
MACLEODS PHARMS LTDANDA 2092832018
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Rx | AT |
CHARTWELL RXANDA 2075382017
CHARTWELL RXANDA 2075382017
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | OINTMENT | TOPICAL | Rx | AB |
NOVEL LABS INCANDA 2060032017
NOVEL LABS INCANDA 2060032017
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Rx | AT |
FOUGERA PHARMS INCANDA 2007352014
FOUGERA PHARMS INCANDA 2007352014
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.1% | CREAM | TOPICAL | Rx | AB |
GLENMARK PHARMS LTDANDA 0912822014
GLENMARK PHARMS LTDANDA 0912822014
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.1% | CREAM | TOPICAL | Discontinued | — |
SUN PHARMA CANADAANDA 2007342014
SUN PHARMA CANADAANDA 2007342014
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.1% | CREAM | TOPICAL | Rx | AB |
PADAGIS ISRAELANDA 0902562014
PADAGIS ISRAELANDA 0902562014
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.1% | CREAM | TOPICAL | Discontinued | — |
FOUGERA PHARMSANDA 0765862004
FOUGERA PHARMSANDA 0765862004
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB2 |
SUN PHARMA CANADAANDA 0750081999
SUN PHARMA CANADAANDA 0750081999
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | OINTMENT | TOPICAL | Rx | AB |
FOUGERA PHARMSANDA 0749051997
FOUGERA PHARMSANDA 0749051997
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | OINTMENT | TOPICAL | Rx | AB |
SUN PHARMA CANADAANDA 0749351997
SUN PHARMA CANADAANDA 0749351997
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | GEL | TOPICAL | Rx | AB |
SUN PHARMA CANADAANDA 0747991996
SUN PHARMA CANADAANDA 0747991996
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Rx | AT |
COSETTE PHARMS NCANDA 0742041995
COSETTE PHARMS NCANDA 0742041995
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB2 |
FOUGERA PHARMS INCANDA 0729341995
FOUGERA PHARMS INCANDA 0729341995
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Rx | AT |
FOUGERA PHARMS INCANDA 0729331994
FOUGERA PHARMS INCANDA 0729331994
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | GEL | TOPICAL | Rx | AB |
FOUGERA PHARMS INCANDA 0730301994
FOUGERA PHARMS INCANDA 0730301994
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB1 |
COSETTE PHARMS NCANDA 0730851992
COSETTE PHARMS NCANDA 0730851992
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB1 |
TEVAANDA 0734811991
TEVAANDA 0734811991
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | OINTMENT | TOPICAL | Rx | AB |
TEVA PHARMSANDA 0725221990
TEVA PHARMSANDA 0725221990
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Discontinued | — |
SUN PHARMA CANADAANDA 0728571989
SUN PHARMA CANADAANDA 0728571989
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Discontinued | — |
TEVAANDA 0724901989
TEVAANDA 0724901989
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB2 |
COSETTEANDA 0725371989
COSETTEANDA 0725371989
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | GEL | TOPICAL | Discontinued | — |
TEVAANDA 0725111989
TEVAANDA 0725111989
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Discontinued | — |
TEVAANDA 0724881989
TEVAANDA 0724881989
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB1 |
TAROANDA 0724941989
TAROANDA 0724941989
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB2 |
COSETTEANDA 0715351988
COSETTEANDA 0715351988
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | SOLUTION | TOPICAL | Discontinued | — |
PERRIGO NEW YORKANDA 0717901988
PERRIGO NEW YORKANDA 0717901988
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Discontinued | — |
SUN PHARMA CANADAANDA 0715001987
SUN PHARMA CANADAANDA 0715001987
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 0.05% | CREAM | TOPICAL | Rx | AB1 |
Orange Book patent file
Listed patents
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
FDA approval span
Approval history
First approval
Apr 06, 1984
42 yr 11 mo ago
Most recent approval
Feb 26, 2025
1 yr 5 mo ago
Approvals span 1984–2025 across 47 FDA applications.
Brand (NDA) 613%
Generic (ANDA) 4187%
Fluocinonide — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

